Blogs

As any case manager knows, making a referral can be a challenge, since many fall by the wayside during transition to another provider, different therapist, etc.

So-called “Dr. Feelgoods” have been around for as long as I can remember.

Many new programs are started in the hopeful expectation that they’ll become self-supporting within a few years.

There are just too many ways to get drugs across borders for a fence or a wall to make that much difference.

Despite the collateral damage, Big Pharma seems determined to preserve the market for its products, through sophisticated lobbying.

From a patient’s viewpoint, physicians can be somewhat blase’ about risks associated with a medication.

It may be that kratom is a drug that some can use without much difficulty, while for others, it becomes pathological.

Addiction programs, conversely, targeted elimination or at least substantial reduction in substance use– a narrower goal that permitted greater focus in treatment.

Willing not only to think outside the box, but to stomp the box flat if need be.

But now we’ll be contending with business interests that actively promote cannabis the way the tobacco and liquor industries promote their products– but with even less restriction